Excited to share our new paper! Wild-type GL261 and CT2A GBM models are resistant to RT. Tumors treated with RT + single ICB (PD-1 or CTLA-4) remain resistant. Only RT+anti-PD-1+anti-CTLA-4 led to 100% long-term survival in mice. Proud of this team effort! www.sciencedirect.com/science/arti...